A once-weekly injection of Wegovy® has become available in Singapore, marking the latest step in managing obesity as a ...

Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.

Novo Nordisk NVO announced that it has submitted a regulatory application to the European Medicines Agency (EMA) seeking ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

Novo Nordisk submits a higher 7.2 mg dose of Wegovy for EMA approval, backed by trials showing 21% weight loss in obesity and ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...

Now, healthcare specialists at ZAVA have put together a step-by-step guide on what to expect if you are taking the jabs. Dr ...

With Mounjaro being rolled out at GPs down south, experts have listed the reasons why people getting the jabs may still not ...

GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a new study into side effects of GLP-1 medicines (glucagon-like peptide-1 receptor agonists) ...

Weight loss drugs Mounjaro and Wegovy, as well as diabetes jab Ozempic may be linked to life-threatening health problems ...